GLP1R and type 2 diabetes mellitus: ,10 Semaglutide is a GLP-1 analogue that is available as a once-weekly subcutaneous (s.c.; at doses up to 2.0 mg) and a once-daily oral (at doses up to 14 mg) formulation for the treatment of type 2 diabetes.11